Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline in late-life depression
NCT01896934Phase 4Completed
- Sponsor
- Vanderbilt University
- Start
- Jul 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sertraline in major depressive disorder (MDD), sponsored by Vanderbilt University. Primary endpoint: Remission of Depression at 12 weeks. Started Jul 2013; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01896934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896934.